Willingness to pay for an mRNA-based anti-cancer treatment: results from a contingent valuation study in Israel

Willingness to pay for an mRNA-based anti-cancer treatment: results from a contingent valuation study in Israel

Abstract Background mRNA technology is currently being investigated for a range of oncology indications. We assessed the willingness to pay (WTP) of the general population in Israel for a hypothetical novel mRNA-based treatment for oncology indications. Methods We used a contingent valuation methodo...

Full description

Bibliographic Details
Main Authors: Omer Ben-Aharon, Ruslan Sergienko, Georgi Iskrov, Dan Greenberg
Format: Article
Language:English
Published: BMC 2024-02-01
Series:Israel Journal of Health Policy Research
Subjects:
Cancer
Oncology
Willingness to pay (WTP)
Contingent valuation
mRNA
Online Access:https://doi.org/10.1186/s13584-024-00594-z

Similar Items

Similar Items